News + Filings Holdings
All
13F
13D/G
Other
|
|
Cormorant Global Healthcare Master Fund, LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Bought 58,839 shares
@ $59.8973, valued at
$3.5M
|
|
| 10/04/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics|
Txns:
| Bought 74,911 shares
@ $57.37, valued at
$4.3M
Bought 150,487 shares
@ $57.252, valued at
$8.6M
Bought 67,814 shares
@ $57.3188, valued at
$3.9M
|
|
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
SC 13G/A
| Cormorant Global Healthcare Master Fund, LP reports a 7.4% stake in Praxis Precision Medicines, Inc. |
| 06/16/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 6,989 options to buy
@ $38.9, valued at
$271.9k
|
|
| 06/08/2023 |
3
| Cormorant Asset Management, LP (See below) has filed a Form 3 on GreenLight Biosciences Holdings, PBC |
| 06/08/2023 |
SC 13D
| Cormorant Global Healthcare Master Fund, LP reports a 6.1% stake in GreenLight Biosciences Holdings, PBC |
| 05/01/2023 |
SC 13G/A
| Cormorant Global Healthcare Master Fund, LP reports a 9.3% stake in EyePoint Pharmaceuticals, Inc. |
| 04/24/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2023 |
SC 13D/A
| Cormorant Global Healthcare Master Fund, LP reports a 10.2% stake in Biomea Fusion, Inc. |
| 04/03/2023 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Bought 400,000 shares
@ $30, valued at
$12M
|
|
| 03/16/2023 |
4
| Cormorant Asset Management, LP (10% Owner) has filed a Form 4 on Ambrx Biopharma Inc.|
Txns:
| Bought 250,000 shares
@ $9.9531, valued at
$2.5M
Bought 250,000 shares
@ $10.5955, valued at
$2.6M
Bought 500,000 shares
@ $10.1485, valued at
$5.1M
|
|
| 03/13/2023 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Ambrx Biopharma Inc. |
| 02/14/2023 |
SC 13G/A
| Cormorant Global Healthcare Master Fund, LP reports a 4.7% stake in Edgewise Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Cormorant Global Healthcare Master Fund, LP reports a 10% stake in Rain Oncology Inc. |
| 12/21/2022 |
4/A
| Chen Bihua (Director) has filed a Form 4 on Erasca, Inc.|
Txns:
| Bought 307,692 shares
@ $6.5, valued at
$2M
|
|
| 12/20/2022 |
4
| Chen Bihua (Director) has filed a Form 4 on Erasca, Inc.|
Txns:
| Bought 307,692 shares
@ $6.5, valued at
$2M
|
|
| 06/24/2022 |
4
| Chen Bihua (10% Owner) has filed a Form 4 on Biomea Fusion, Inc.|
Txns:
| Granted 23,867 options to buy
@ $10.2, valued at
$243.4k
|
|
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| Cormorant Global Healthcare Master Fund, LP reports a 7.2% stake in Edgewise Therapeutics, Inc. |
| 01/13/2022 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Converted 616,786 shares
@ $0
Converted 616,786 convertible preferred
@ $0 |
|
| 01/06/2022 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Vigil Neuroscience, Inc. |
| 10/27/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Ventyx Biosciences, Inc.|
Txns:
| Converted 785,303 shares
@ $0
Bought 625,000 shares
@ $16, valued at
$10M
Converted 548,288 convertible preferred
@ $0
Converted 237,015 convertible preferred
@ $0 |
|
| 10/20/2021 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Ventyx Biosciences, Inc. |
| 10/15/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Pyxis Oncology, Inc.|
Txns:
| Converted 668,854 shares
@ $0
Bought 450,000 shares
@ $16, valued at
$7.2M
Converted 668,854 convertible preferred
@ $0 |
|
| 10/07/2021 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Pyxis Oncology, Inc. |
| 09/21/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Tyra Biosciences, Inc.|
Txns:
| Converted 757,432 shares
@ $0
Bought 312,500 shares
@ $16, valued at
$5M
Converted 757,432 convertible preferred
@ $0 |
|
| 09/14/2021 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Tyra Biosciences, Inc. |
| 08/05/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Immuneering Corp|
Txns:
| Converted 1,702,628 shares
@ $0
Bought 550,000 shares
@ $15, valued at
$8.3M
Converted 1,702,628 convertible preferred
@ $0 |
|
| 08/04/2021 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Icosavax, Inc.|
Txns:
| Converted 426,393 shares
@ $0
Converted 426,393 convertible preferred
@ $0 |
|
| 07/29/2021 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Immuneering Corp |
| 07/28/2021 |
3
| Cormorant Asset Management, LP (10% Owner) has filed a Form 3 on Icosavax, Inc. |
|
|
|